Expression of TNF-α in oral lichen planus treated with fluocinolone acetonide 0.1%

Journal of Oral Pathology and Medicine

Volumn 35, Issue 3, 2006, Pages 161-166

  Thongprasom, Kobkan ^a   Dhanuthai, Kittipong ^a   Sarideechaigul, Wilairat ^a   Chaiyarit, Ponlatham ^b   Chaimusig, Mantharop ^c  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b KHON KAEN UNIVERSITY   (Thailand)

^c Saraburi Hospital   (Thailand)

Author keywords

Fluocinolone acetonide; Oral lichen planus; Tumor necrosis factor

Indexed keywords

FLUOCINOLONE ACETONIDE; FLUOCINOLONE ACETONIDE IN ORABASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL COUNT; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; LICHEN PLANUS; MALE; MONONUCLEAR CELL; MOUTH INFLAMMATION; MOUTH LICHEN PLANUS; MOUTH MUCOSA; ORAL BIOPSY; PRIORITY JOURNAL; PROTEIN EXPRESSION; THAILAND;

ADOLESCENT; ADULT; AGED; CARBOXYMETHYLCELLULOSE; FEMALE; FLUOCINOLONE ACETONIDE; GLUCOCORTICOIDS; HUMANS; LICHEN PLANUS, ORAL; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33645219098     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2006.00392.x     Document Type: Article

References (23)

1. Iijima W Ohtani H Nakayama T et al. Infiltrating CD8+ T cells in oral lichen planus predominantly express CCR5 and CXCR3 and carry respective chemokine ligands RANTES/CCL5 and IP-10/CXCL 10 in their cytolytic granules: a potential self-recruiting mechanism. Am J Pathol 2003 163 261 8.
2. Lodi G Scully C Carrozzo M Griffiths M Sugerman PB Thongprasom K. Current controversies in oral lichen planus; report of an international consensus meeting: Part 1. Viral infections and aetiopathogenesis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005 100 40 51.
3. Sugerman PB Savage NW Walsh LJ et al. The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med 2002 13 350 65.
4. Sugerman PB Savage NW Seymour GJ Walsh LJ. 'Is there a role for tumor necrosis factor-alpha (TNF-α) in oral lichen planus' J Oral Pathol Med 1996 25 219 24.
5. Thornhill MH. Immune mechanisms in oral lichen planus. Acta Odontal Scand 2001 59 174 7.
6. Vilcek J Lee TH. Tumor necrosis factor. New insights into the molecules mechanisms of its multiple actions. J Biol Chem 1991 266 7313 6.
7. Vasalli P. The pathophysiology of tumor necrosis factor. Annu Rev Immunol 1992 10 411 52.
8. Banno T Gazel A Blumenberg M. Effects of tumor necrosis factor-α (TNF-α) in epidermal keratinocytes revealed using global transcriptional profiling. J Biol Chem 2004 279 32633 42.
9. Lodi G Scully C Carrozzo M Griffiths M Sugerman PB Thongprasom K. Current controversies in oral lichen planus; report of an international consensus meeting: Part 2. Clinical management and malignant transformation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005 100 164 78.
10. Thongprasom K Luengvisut P Wongwatanakit A Boonjatturus C. Clinical evaluation in treatment of oral lichen planus with topical fluocinolone acetonide: a 2-year follow-up. J Oral Pathol Med 2003 32 315 22.
11. Sklavounou A Chrysomali E Scorilas A. TNF-α expression and apoptosis-regulating proteins in oral lichen planus: a comparative immunohistochemical evaluation. J Oral Pathol Med 2000 29 370 5.
12. Walsh LJ Savage NW Ishii T Seymour GJ. Immunopathogenesis of oral lichen planus. J Oral Pathol Med 1990 19 389 96.
13. Moses MA Marikovsky M Harper JW et al. Temporal study of the activity of matrix metalloproteinases and their endogenous inhibitors during wound healing. J Cell Biochem 1996 60 379 86.
14. Imaizumi T Itaya H Fujita K et al. Expression of tumor necrosis factor-α in cultured human endothelial cells stimulated with lipopolysaccharide or interleukin-1α. Arterioscler Thromb Vasc Biol 2000 20 410 5.
15. Sukedai M Tominaga K Habu M et al. Involvement of tumor necrosis factor-α and interleukin-8 in antigen-induced arthritis of the rabbit temporomandibular joint. J Oral Pathol Med 2004 33 102 10.
16. Younes F Quartey EL Kiguwa S Partridge M. Expression of TNF and the 55-kDa TNF receptor in epidermis, oral mucosa, lichen planus and squamous cell carcinoma. Oral Dis 1996 2 25 31.
17. Rhodus NL Cheng B Myers S Bowles W Ho V Ondrey F. A comparison of the pro-inflammatory, NF-kB-dependent cytokines: TNF-alpha, IL-1- alpha, IL-6, and IL-8 in different oral fluids from oral lichen planus patients. Clin Immunol 2005 114 278 83.
18. Sklavounou-Andrikopoulou A Chrysomali E Iakovou M Garinis GA Karameris A. Elevated serum levels of the apoptosis related molecules TNF-alpha, Fas/Apo-1 and Bcl-2 in oral lichen planus. J Oral Pathol Med 2004 33 386 90.
19. Pezelj-Ribaric S Prso IB Abram M Glazar I Brumini G Simunovic-Soskic M. Salivary levels of tumor necrosis factor-alpha in oral lichen planus. Mediators Inflamm 2004 13 131 3.
20. Baugh JA Bucala R. Mechanisms for modulating TNF alpha in immune and inflammatory disease. Curr Opin Drug Discov Devel 2001 4 635 50.
21. Tracey KJ Cerami A. Tumor necrosis factor, other cytokines and disease. Annu Rev Cell Biol 1993 9 317 43.
22. Antoni C Braun J. Side effects of anti-TNF therapy: current knowledge. Clin Exp Rheumatol 2002 20 S152 7.
23. Mor A Bingham C III. Barisoni L Lydon E Belmont HM. Proliferative lupus nephritis and leukocytoclastic vasculitis during treatment with etanercept. J Rheumatol 2005 32 740 3.